As a Free StocksGuide user, you can view scores for all 7,024 stocks worldwide.
7 Analysts have issued a MyMD Pharmaceuticals Inc forecast:
7 Analysts have issued a MyMD Pharmaceuticals Inc forecast:
| Sep '23 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | - - |
-
|
|
| EBIT (Operating Income) EBIT | -16 -16 |
5%
5%
|
|
| Net Profit | -7.08 -7.08 |
52%
52%
|
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
MyMD Pharmaceuticals, Inc. is a clinical stage pharmaceutical company which engages in extending healthy lifespan. It involves in developing and commercializing therapeutic platforms based on well-defined therapeutic targets, MYMD-1 and Supera-CBD. The company is headquartered in Baltimore, MD.
| Head office | United States |
| CEO | Christopher Chapman |
| Founded | 1989 |
| Website | tnfpharma.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


